Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial



Status:Recruiting
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:16 - Any
Updated:3/28/2019
Start Date:February 8, 2017
End Date:August 2021
Contact:Shannon Martin, RN
Email:martins@wudosis.wustl.edu
Phone:314 362-8523

Use our guide to learn which trials are right for you!

Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean: a Multicenter Randomized Trial

The Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean Trial is a large
pragmatic multi-center randomized clinical trial designed to evaluate the effectiveness,
safety and cost-effectiveness of prophylactic negative pressure wound therapy (NPWT) - a
closed, sealed system that applies negative pressure to the wound surface via a single-use,
battery-powered, portable device - to decrease surgical site infections (SSIs) in obese
women.

Experimental evidence suggests that NPWT promotes wound healing by removing exudate,
approximating the wound edges, and reducing bacterial contamination. Obesity (body mass index
[BMI] ≥30kg/m2) increases the risk for both cesarean delivery and SSIs compared to non-obese
women. The increased risk of SSIs is in part due to the increased thickness of the
subcutaneous space, allowing collection of exudates and increasing tension on wound edges,
promoting the growth of bacteria, and leading to wound infection and breakdown. Thus,
prophylactic NPWT may be particularly effective in this patient population.

During the 5-year project period, investigators from 4 collaborating perinatal centers in the
United Stated (two university and two community) will randomize 2850 obese women undergoing
cesarean delivery to receive either prophylactic negative pressure wound therapy with the
Prevena device or standard wound dressing. Women will be followed up to 30 days
postoperatively to ascertain study outcomes.

The primary outcome for the trial is superficial or deep SSI after cesarean according to the
CDC's National Healthcare Safety Network definitions. The investigators will also assess
other wound complications, adverse events potentially attributable to NPWT and
cost-effectiveness as measured by incremental cost per case of SSI prevented and per
quality-adjusted life year (QALY).

Inclusion Criteria

- Gestational age ≥23weeks

- BMI≥30 Pre-pregnancy or BMI at first prenatal visit

- Planned or unplanned cesarean delivery

Exclusion Criteria:

- Non-availability for postoperative follow-up

- Contraindication to NPWT applicable to women undergoing cesarean: Pre-existing
infection around incision site, Bleeding disorder, Therapeutic anticoagulation,
Irradiated skin, Allergy to any component of the dressing (e.g. silver, acrylic,
silicone, adhesive tape)
We found this trial at
5
sites
Birmingham, Alabama 35233
Principal Investigator: Lorie Harper, MD, MSCI
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
New Orleans, Louisiana 70115
Principal Investigator: Sherri Longo, MD
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Principal Investigator: Methodius G Tuuli, MD, MPH
Phone: 314-362-4224
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Saint Louis, Missouri 63141
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials